Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Fragos

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Cardiology Reports|January 14, 2025
Multi-Modality Imaging in Cardio-RheumatologyVasiliki Vartela, Alessia Pepe, Ioannis Fragos, et al.
Anticancer Research|November 27, 2008
Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimenAlexandros Ardavanis, Panteleimon Kountourakis, Ioannis Mantzaris, et al.
Anticancer Research|August 30, 2008
Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicityAlexandros Ardavanis, Stella Koumna, Ioannis Fragos, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Cardiology Reports|January 14, 2025
Multi-Modality Imaging in Cardio-RheumatologyVasiliki Vartela, Alessia Pepe, Ioannis Fragos, et al.
Anticancer Research|November 27, 2008
Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimenAlexandros Ardavanis, Panteleimon Kountourakis, Ioannis Mantzaris, et al.
Anticancer Research|August 30, 2008
Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicityAlexandros Ardavanis, Stella Koumna, Ioannis Fragos, et al.
Pageof 1